Benzinga | Feb 25, 2021 04:40PM EST

Health Catalyst Q4 EPS $(0.16) Beats $(0.19) Estimate, Sales $53.28M Beat $52.12M Estimate

Health Catalyst (NASDAQ:HCAT) reported quarterly losses of $(0.16) per share which beat the analyst consensus estimate of $(0.19) by 15.79 percent. This is a 23.81 percent increase over losses of $(0.21) per share from the same period last year. The company reported quarterly sales of $53.28 million which beat the analyst consensus estimate of $52.12 million by 2.22 percent. This is a 22.48 percent increase over sales of $43.50 million the same period last year.